EDGAR Filing Documents for 0001610618-22-000007

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001610618-22-000007

Filing Date

2022-03-07

Accepted

2022-03-07 17:12:46

Documents

Period of Report

2021-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	CIDARA THERAPEUTICS, INC. 2021 FORM 10-K	cdtx-20211231.htm iXBRL	10-K	2034376
2	AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY	exhibit1052021-12.htm	EX-10.5	16923
3	FIFTH AMENDMENT TO LEASE DATED JANUARY 13, 2020	exhibit10262021-12.htm	EX-10.26	8933
4	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	exhibit2312021-12.htm	EX-23.1	3400
5	CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934	exhibit3112021-12.htm	EX-31.1	11552
6	CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934	exhibit3122021-12.htm	EX-31.2	11763
7	CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002	exhibit3212021-12.htm	EX-32.1	6901
8	CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002	exhibit3222021-12.htm	EX-32.2	7156
14	GRAPHIC	cdtx-20211231_g1.jpg	GRAPHIC	83959
	Complete submission text file	0001610618-22-000007.txt		8225111

Data Files

Seq	Description	Document	Type	Size
9	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	cdtx-20211231.xsd	EX-101.SCH	50777
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	cdtx-20211231_cal.xml	EX-101.CAL	65411
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	cdtx-20211231_def.xml	EX-101.DEF	300784
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	cdtx-20211231_lab.xml	EX-101.LAB	655748
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	cdtx-20211231_pre.xml	EX-101.PRE	425786
67	EXTRACTED XBRL INSTANCE DOCUMENT	cdtx-20211231_htm.xml	XML	1215060

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121

Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170

Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)